In viewing TWEAK’s pro-proliferative and apoptosis-blockade activities in HCC, alongside the relative refractoriness of this tumor type to TRAIL-induced apoptosis, we posited that there may be functional cross-talk between these TNF pathways wherein TWEAK signaling contributes to TRAIL-resistance. This evidence concerns the gene TNFSF12 and hepatocellular carcinoma.